Viking Therapeutics (VKTX) Misses Q3 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.22), $0.02 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Morgan Stanley lifts server market TAM to $809B, boosts targets on compute stocks
• Qualcomm investor day to detail data center plans Wednesday